[Short-term lysis of venous thrombosis with ultra-high streptokinase doses]
- PMID: 2427419
[Short-term lysis of venous thrombosis with ultra-high streptokinase doses]
Abstract
11 patients with deep pelvic and leg vein thrombosis were treated with ultra-high streptokinase infusion, 1.5. 10(6) IE streptokinase per hour over a six hour period. Opening of the vein occlusion was achieved in four cases completely and in five cases partially. The frequency of complications was lower at short-time thrombolysis with ultra-high streptokinase infusion in contrast to long-time thrombolysis. Bleedings did not occur. Because of the slight side effects ultra-high streptokinase infusion is an alternative in the fibrinolytic treatment of risk patients with pelvic and leg vein thrombosis.
Similar articles
-
[Ultra-high dose thrombolytic therapy with streptokinase in peripheral venous thrombosis].Med Klin (Munich). 1989 Apr 15;84(4):183-7, 226. Med Klin (Munich). 1989. PMID: 2725427 German.
-
[Results of ultra-high streptokinase (Awelysin) doses in patients with thrombophlebitis].Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(1-2):75-81. Folia Haematol Int Mag Klin Morphol Blutforsch. 1986. PMID: 2427418 German.
-
Fibrinolytic treatment with ultra-high streptokinase infusion via the dorsalis pedis vein offers no advantage over systemic infusion via the brachial vein in patients with deep vein thrombosis of the leg.Vasa. 1996;25(3):275-8. Vasa. 1996. PMID: 8795307 Clinical Trial.
-
[Heparin or thrombolysis in the treatment of deep venous thrombosis of the leg].Vasa. 1974;3(4):422-32. Vasa. 1974. PMID: 4613050 Review. German. No abstract available.
-
Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature.Am J Med. 1990 Apr;88(4):389-95. doi: 10.1016/0002-9343(90)90494-x. Am J Med. 1990. PMID: 2183600 Review.